FAST-ACT: A phase II randomized double-blind trial of sequential erlotinib and chemotherapy as first-line treatment in patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC)

Autor: Jorge Ignacio, Jin Soo Lee, Chong-Jen Yu, Yi-Long Wu, Li Zhang, Michael R. Johnston, Tony Mok, Yuh Min Chen, Kate Jin, Caicun Zhou
Rok vydání: 2008
Předmět:
Zdroj: Journal of Clinical Oncology. 26:8031-8031
ISSN: 1527-7755
0732-183X
DOI: 10.1200/jco.2008.26.15_suppl.8031
Popis: 8031 Background: Concurrent administration of EGFR TKIs and chemotherapy in 1st line failed to improve survival. Preclinical data suggested potential antagonism due to TKI-induced G1 arrest reducin...
Databáze: OpenAIRE